Form D · Biotechnology
Third Arc Bio, Inc.
Lower Gwynedd, PA · CIK 0002032467
Offering snapshot reported Aug 1, 2024 · SEC filing
- Reported sold
- $72.5M Offering amount: $165M
- Investors reported
- 32 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 16, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 1, 2024 | Initial | $72,499,974 | No comparison | 32 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-520369
Source: Form D, filed Aug 1, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Francesco Draetta | Director |
| Joseph Erhardt | Executive |
| Arjun Goyal | Director |
| Peter Lebowitz | Director, Executive |
| Otello Stampacchia | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
727 Norristown Road, Bldg 8 Suite 320
Lower Gwynedd, PA, 19002
Lower Gwynedd, PA, 19002